BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han L, Wang S, Wei C, Fang Y, Huang S, Yin T, Xiong B, Yang C. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer. Expert Rev Mol Med 2021;23:e16. [PMID: 34758892 DOI: 10.1017/erm.2021.13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Qi J, Guo T, Li J. Research progress of Astragalus membranaceus in treating peritoneal metastatic cancer. J Ethnopharmacol 2023;305:116086. [PMID: 36587879 DOI: 10.1016/j.jep.2022.116086] [Reference Citation Analysis]
2 Quan Q, Wu J, Yu M, Tang J. Immune micro-environment and drug analysis of peritoneal endometriosis based on epithelial-mesenchymal transition classification. Front Endocrinol (Lausanne) 2022;13:1035158. [PMID: 36523599 DOI: 10.3389/fendo.2022.1035158] [Reference Citation Analysis]
3 Zheng SM, Chen H, Sha WH, Chen XF, Yin JB, Zhu XB, Zheng ZW, Ma J. Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet. World J Gastroenterol 2022; 28(34): 4993-5006 [PMID: 36160648 DOI: 10.3748/wjg.v28.i34.4993] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qu X, Zhao X, Lin K, Wang N, Li X, Li S, Zhang L, Shi Y. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma. Front Immunol 2022;13:994019. [DOI: 10.3389/fimmu.2022.994019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang W, Jiang Z, Tang D. The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications. Clin Transl Oncol 2022. [PMID: 35921060 DOI: 10.1007/s12094-022-02908-6] [Reference Citation Analysis]
6 Pouliquen DL, Boissard A, Henry C, Coqueret O, Guette C. Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. Front Pharmacol 2022;13:934534. [DOI: 10.3389/fphar.2022.934534] [Reference Citation Analysis]
7 Li C, Kuang K, Du J, Eymin B, Jia T. Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer. Biochim Biophys Acta Mol Cell Res 2022;1869:119253. [PMID: 35259425 DOI: 10.1016/j.bbamcr.2022.119253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tian Y, Cheng C, Wei Y, Yang F, Li G. The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation. Cells 2022;11:1005. [DOI: 10.3390/cells11061005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]